As of Nov 27
| +1.41 / +1.72%|
The 10 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 94.00, with a high estimate of 133.00 and a low estimate of 75.00. The median estimate represents a +12.59% increase from the last price of 83.49.
The current consensus among 11 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.